Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys Expanded Access in CML
NCT02736721Phase 3Completed
- Sponsor
- Roche
- Start
- Sep 2003
- Primary completion
- Nov 2010
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of pegylated interferon alpha in chronic myelogenous leukemia (CML), sponsored by Roche. Started Sep 2003; status: completed.
02
Drugs
pegylated interferon alpha
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on NCT02736721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02736721.